期刊文献+

川崎病T细胞免疫及细胞因子变化的研究 被引量:14

Research on T cell immunity and change of cytokines in Kawasaki disease
下载PDF
导出
摘要 目的探讨川崎病(Kawasaki disease,KD)时细胞免疫功能及一些细胞因子在疾病发生发展中的变化。方法 2003年1月-2007年10月在我院住院的KD患者52例、热性对照42例、正常对照30例,采用酶联免疫吸附试验(enzyme-linked immunosorbent assay,ELISA)检测三组血清巨噬细胞迁移抑制因子(macrophage migration inhibitory factor,MIF)、白细胞介素-6(interleukin-6,IL-6)、肿瘤坏死因子α(tumor necrosis factor-α,TNF-α)、白细胞介素-1β(interleukin-1β,IL-1β),采用流式细胞术检测川崎病患者的细胞免疫功能。其中川崎病患者分别于急性期(发病第1-11天)与亚急性期(发病第11-21天)各检测一次。结果川崎病急性期T淋巴细胞CD4无明显变化,CD8比例减少,CD4/CD8比值明显增高(P<0.01);川崎病患儿急性期血清MIFI、L-6、TNF-αI、L-1β水平明显升高(P<0.01);川崎病患儿亚急性期血清MIFI、L-6、TNF-αI、L-1β水平较急性期明显下降(P<0.01);川崎病同一个体不同病程期间,血清MIF和IL-6水平有很好的相关性,特别是急性期患儿二者呈正相关(r=0.87,P=0.017)。结论川崎病急性期细胞免疫系统处于活化状态,活化的T细胞分泌高浓度的炎性细胞因子如IL-1I、L-6、MIF和TNF-α等,引起一系列的血管炎性改变和脏器损伤。检测血清MIF和IL-6水平,可望作为川崎病患儿急性期的一个判断指标。 Objective This study expored the changes of T cell function and some cytokines in KD.Methods Serum samples were collected from 52 patients with KD,30 normal healthy subjects,and 42 febrile control subjects,respectively.The serum levels of CD3,CD4 and CD8 positive T cell was detected by flow cytometry.Cytokines,including MIF,IL-6,TNF-α and IL-1β were assayed by ELISA.Results The absolute counts of CD3+ and CD4+ T cells had no obvious changes while the absolute counts of CD8+ T cells decreased in KD during the acute stage,and the level of CD4/CD8 increased observably.There was a significant increase in the serum levels of MIF,TNF-α,IL-6 and IL-1β in the acute stage of KD compared with those in the subacute stage(P〈0.01) and normal controls(P〈0.001),and febrile controls(p = 0.01).And there was also a correlation between the serum levels of MIF and IL-6 in patents with KD,especially in the acute stage(r=0.87,P=0.017).Conclusion There was a activation of peripheral blood T cells immune function,especially the increasing level of CD4/CD8 at the acute stage in KD,this lead to the secretion of a lot of cytokines,such as MIF,IL-6,TNF-α and IL-1β,these cytokines were involved in the pathology and pathogenesis cause of KD.
出处 《中国实验诊断学》 北大核心 2011年第9期1533-1536,共4页 Chinese Journal of Laboratory Diagnosis
关键词 川崎病 T细胞免疫 细胞因子 Kawasaki disease T cell immune function Cytokines
  • 相关文献

参考文献13

  • 1Shulman ST,Rowley AH:Advances in Kawasaki disease[J].Eur J Pediatr 2004,163(6):285.
  • 2Satou GM,Giamelli J,Gewitz MH.Kawasaki disease:diagnosis,management,and long-term implications[J].Cardiol Rev,2007,15(4):163.
  • 3Hibbard JU,Fajardo JE,Briller J.Kawasaki disease with coronary artery sequelae[J].Obstet Gynecol,2007,109(2 Pt2):517.
  • 4Wong D,Harder J,Jadavji T.Kawasaki disease,myocardial infarction and coronary artery revascularization[J].Can J Cardiol,2005,21(7):601.
  • 5Newburger JW,Takahashi M,Gerber MA,et al:Diagnosis,treatment,and long-term management of Kawasaki disease:a statement for health professionals from the Committee on Rheumatic Fever,Endocarditis and Kawasaki Disease,Council on Cardiovascular Disease in the Young,American Heart Association[J].Circulation,2004,110(17):2747.
  • 6胡亚美,江载芳.诸福棠实用儿科学[M].第7版.北京:人民卫生出版社.2005.1856.
  • 7Uehara R,Yashiro M,Nakamura Y,et al.Kawasaki disease in parents and children[J].Acta Paediatr,2003,92(6):694.
  • 8郑淑梅,刘文彬,王太森,张宏伟,周颖.细胞免疫功能在川崎病发病机制中的作用[J].实用儿科临床杂志,2005,20(7):641-642. 被引量:12
  • 9Lee TJ,Chun JK,Yeon SI,et al.Increased serum levels of macrophage migration inhibitory factor in patients with Kawasaki disease[J].Scand J Rheumatol,2007,36(3):222.
  • 10Korematsu S,Uchiyama S,Miyahara H,et al.The characterization of cerebrospinal fluid and serum cytokines in patients with Kawasaki disease[J].Pediatr Infect Dis J,2007,26(8):750.

二级参考文献24

  • 1冀石梅,梁翊常,夏淑筠.川崎病患儿血浆内皮素检测与冠状动脉病变[J].实用儿科临床杂志,2004,19(8):656-657. 被引量:8
  • 2于宪一.川崎病治疗的现状和展望[J].实用儿科临床杂志,2004,19(11):922-924. 被引量:42
  • 3吴瑞萍 胡亚美.诸福棠实用儿科学(第6版)[M].北京:人民卫生出版社,1995.499-454.
  • 4Lazarus M, Hajeer AH, Turner D, et al. Genetic variation in the interleukin 10 8ene promoter and systemic lupus erythematosus.J Rheumatol, 1997, 24:2314-2317.
  • 5Hurme M, Lahdenpohja N, Santtila S. Gene polymorphisms of interleukins 1 and 10 in infectious and autoimmune diseases. Ann Med, 1998.30:469-473.
  • 6Kamizono S, Yamada A, Higuchi T,et al. Analysis of tumor necrosis factor-alpha production and polymorphisms of the tumor necrosis factor-alpha gene in individuals with a history of Kawasaki disease.Pediatr Int, 1999,41:341-345.
  • 7Quasney MW, Brornstein DE, Cantor RM, et al. Increased frequency of alleles associated with elevated tumor necrosis factor-alpha levels in children with kawasaki disease. Pediatr Res , 2001,49:686-690.
  • 8Mok CC, Lanchbury JS, Chan DW, et al. Interleukin-10 promoter polymorphism in Southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum, 1998,41:1090-1095.
  • 9Matsubara T, Furukawa S, Yabuta K. Serum levels of tumor necrosis factor interleukin 2 receptor, and intederon-ganuna in Kawasaki disease involved coronary-artery lesions. Clin Immunol Immunopsathol, 1990, 56:29-36.
  • 10Wright DA, Newburger JW, Baker A, et al. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids. J Pediatr, 1996,128:146-149.

共引文献43

同被引文献134

引证文献14

二级引证文献76

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部